1,2,3-Tri-O-acetyl-5-deoxy-beta-D-ribofuranose
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Pharmaceutical Intermediates
Lianyungang Jinkang Pharmaceutical Technology co., ltd.
- Country / Year Established
-
China
/
- Business type
- Others
- Verified Certificate
-
14
| Product name | 1,2,3-Tri-O-acetyl-5-deoxy-beta-D-ribofuranose | Certification | - |
|---|---|---|---|
| Category | Pharmaceutical Intermediates | Ingredients | - |
| Keyword | 1 , 2 , intermediate , 3-tri-o-acetyl-5-deoxy-beta-d-ribofuranose , 62211-93-2 | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
This is Lianyungang Jinkang Pharmaceutical Technology co., ltd., a professional manufacturer of anticancer/Antineoplastic pharmaceutical intermediates and API's. We are the biggest manufacturer of Gemcitabine HCL and its intermediates in China, taking more than 80 percents market share. Now in Indian market, more than 60% of Gemcitabine intermediates are from our plant.
CAS No.62211-93-2
The intermediate for Capecitabine
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
Lianyungang Jinkang Pharmaceutical Technology co., ltd.
- Country / Year Established
-
China
/
- Business type
- Others
-
14
- President
- Cheng Yongzhi
- Address
- Jinshan Industrial Park, Ganyu county, Lianyungang, Jiangsu province, 222115, China
- Product Category
- Pharmaceutical Intermediates
- No. of Total Employees
- 101-500
- Company introduction
-
Jinkang is a professional middle-size manufacturer of pharmaceutical intermediates and API's. From our establish in 2002, we focus on the development and production of anti-cancer API's and intermediates. Now we are the biggest manufacturer of Gemcitabine int's in China. Our strong products include Gemcitabine, Pemetrexedl, Irinotecan, Etoposide, Mesna and calcium folinate.
In 2009, our sales amount to twelve million US dollars. Our plant has 120 employees, in which 23 are technicals. We have well-equiped Q/C lab, which can complete most of our products' quality test.
- Main Markets
-
China
India
Italy
South Korea
U.S.A
- Factory Information
-
Lianyungang Jinkang Pharmaceutical Technology
- Main Product
